DUBLIN--(BUSINESS WIRE)--The "Food Allergy - Epidemiology Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.
This 'Food Allergy-Epidemiology Forecast - 2032' report delivers an in-depth understanding of the Food Allergy, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Canada and China.
Food Allergy Epidemiology
The Food Allergy epidemiology division provides insights about the historical and current patient pool along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of The report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Key Findings
The disease epidemiology covered in the report provides historical as well as forecasted Food Allergy epidemiology segmented as the Prevalent Cases of Food Allergy, Prevalent Cases of Food Allergy based on Etiology-specific factors, Age-specific Prevalence of Food Allergy. The report includes the prevalent scenario of Food Allergy in 7MM, Canada and China covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), Japan, Canada and China from 2019 to 2032.
Country Wise- Food Allergy Epidemiology
The epidemiology segment also provides the Food Allergy epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan, Canada, and China.
The total prevalent population of Food Allergy associated in 7MM, Canada and China countries was estimated to be 284,023,865 cases in 2019 and expected to increase at a CAGR of 0.18% for the study period, i.e., 2019-2032.
- As per the estimates, CN has the highest prevalent population of Food Allergy in 7MM, Canada and China.
Among the EU-5 countries, Spain had the highest prevalent population of Food Allergy. On the other hand, UK had the lowest number of case 2,007,094 cases in 2019.
Scope of the Report
- Food Allergy report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns.
- Food Allergy Epidemiology Report and Model provide an overview of the risk factors and global trends of Food Allergy in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, Japan, Canada, and China).
- The report provides insight into the historical and forecasted patient pool of Food Allergy in nine major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), Japan, Canada, and China.
- The report helps recognize the growth opportunities in the 7MM, Canada and China concerning the patient population.
- The report assesses the disease risk and burden and highlights the unmet needs of Food Allergy.
- The report provides the segmentation of the Food Allergy epidemiology by prevalent cases of Food Allergy in 7MM, Canada and China.
- The report provides the segmentation of the Food Allergy epidemiology by Prevalent Cases of Food Allergy, Prevalent Cases of Food Allergy based on Etiology-specific factors, Age-specific Prevalence of Food Allergy in 7MM, Canada and China.
Key Topics Covered:
1. Key Insights
2. Report Introduction
3. Food allergy Market Overview at a Glance
3.1. Market Share (%) Distribution of Food allergy in 2019
3.2. Market Share (%) Distribution of Food allergy in 2032
4. Executive Summary of Food allergy
5. Disease Background and Overview
5.1. Introduction
5.2. Etiology
5.3. Clinical Manifestations
5.4. Subtypes of Food Allergy
5.5. Diagnosis
6. Management and Treatment
6.1. Guidelines
6.2. American Guidelines for the Diagnosis and Management of Food allergies
6.3. The European Academy of Allergy and Clinical Immunology (EAACI) Guidelines
6.4. Japanese Guidelines for Food allergies
6.4.1. Symptom Severity and Treatment
6.4.1.1. Grading symptom severity
6.4.1.2. Treatment based on symptom severity
6.4.1.3. Evaluation of organ-specific symptoms
6.4.2. Management of Anaphylaxis in a Health Care Setting
6.4.2.1. Confirmation of vital signs
6.4.2.2. Ensuring staff and treatment by a team
6.4.2.3. Intramuscular injection of adrenaline
6.4.2.4. Body position of the anaphylaxis patients
6.4.2.5. Administration of oxygen
6.4.2.6. Securing the intravenous infusion route and rapid rehydration
6.4.2.7. Cessation of respiration
6.4.2.8. Measurement of vital signs: Re-evaluation
6.4.3. Contraindication of adrenaline
7. Epidemiology and Patient Population
7.1. Key Findings
7.2. 7MM, Canada and China Total Prevalent Patient Population of Food allergy
7.3. Assumption and Rationale
7.4. The United States
7.4.1. Prevalent cases of Food allergy in the United States
7.4.2. Prevalent Cases of Food allergy based on Etiology-specific factors in the United States
7.4.3. Age-specific Prevalence of Food allergy in the United States
7.5. EU5
7.6. Japan
7.7. Canada
7.8. China
8. Patient Journey
For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/364pu3
